{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:11:45Z","timestamp":1771953105376,"version":"3.50.1"},"reference-count":131,"publisher":"Elsevier","isbn-type":[{"value":"9780128162354","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pmbts.2018.07.003","type":"book-chapter","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T23:44:45Z","timestamp":1533858285000},"page":"27-57","source":"Crossref","is-referenced-by-count":40,"title":["Arrestins in the Cardiovascular System: An Update"],"prefix":"10.1016","author":[{"given":"Anastasios","family":"Lymperopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pmbts.2018.07.003_bb0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2018.02.007","article-title":"Biased agonism\/antagonism of cardiovascular GPCRs for heart failure therapy","volume":"339","author":"Desimine","year":"2018","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","article-title":"Structure and dynamics of GPCR signaling complexes","volume":"25","author":"Hilger","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/pr.116.013367","article-title":"The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling","volume":"69","author":"Peterson","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: Pathophysiology and therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0030","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2217\/pgs.14.120","article-title":"Pharmacogenetics of cardiac inotropy","volume":"15","author":"Lymperopoulos","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0035","first-page":"1209","article-title":"Current and future G protein-coupled receptor signaling targets for heart failure therapy","volume":"7","author":"Siryk-Bathgate","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2015.05.019","article-title":"GPCR signaling and cardiac function","volume":"763","author":"Capote","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-12-394440-5.00012-7","article-title":"Arrestins in the cardiovascular system","volume":"118","author":"Lymperopoulos","year":"2013","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.tcb.2017.05.008","article-title":"Novel structural insights into GPCR-\u03b2-arrestin interaction and signaling","volume":"27","author":"Ranjan","year":"2017","journal-title":"Trends Cell Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-018-0079-1","article-title":"Catalytic activation of \u03b2-arrestin by GPCRs","volume":"557","author":"Eichel","year":"2018","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3565(24)29397-6","article-title":"Alpha1-adrenergic receptors: new insights and directions","volume":"298","author":"Piascik","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCHEARTFAILURE.108.846212","article-title":"{alpha}1-adrenergic receptor subtypes in nonfailing and failing human myocardium","volume":"2","author":"Jensen","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ahj.2008.04.004","article-title":"Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: Evidence of improved vascular alpha1-adrenoreceptor signal transduction","volume":"156","author":"Van Tassell","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0080","first-page":"H331","article-title":"Chronic elevation of norepinephrine in conscious dogs produces hypertrophy with no loss of LV reserve","volume":"262","author":"Stewart","year":"2009","journal-title":"Am J Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1161\/01.CIR.0000012750.08480.55","article-title":"Cardiovascular influences of alpha1b-adrenergic receptor defect in mice","volume":"105","author":"Vecchione","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/bs.pmbts.2018.07.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006575","article-title":"\u03b11-Adrenergic receptors function within hetero-oligomeric complexes with atypical chemokine receptor 3 and chemokine (C-X-C motif) receptor 4 in vascular smooth muscle cells","volume":"6","author":"Albee","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/cvr\/cvx036","article-title":"Heterologous desensitization of cardiac \u03b2-adrenergic signal via hormone-induced \u03b2AR\/arrestin\/PDE4 complexes","volume":"113","author":"Shi","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"Suppl B","key":"10.1016\/bs.pmbts.2018.07.003_bb0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/eurheartj\/17.suppl_B.8","article-title":"Cardiac adrenergic receptor effects of carvedilol","volume":"17","author":"Yoshikawa","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0105","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1074\/jbc.M008118200","article-title":"Polymorphic deletion of three intracellular acidic residues of the alpha2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization","volume":"276","author":"Small","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-9-5","article-title":"Impaired desensitization of a human polymorphic \u03b12B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells","volume":"9","author":"Nguyen","year":"2011","journal-title":"Cell Commun Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0735-1097(02)02702-X","article-title":"Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death","volume":"41","author":"Snapir","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0120","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.HYP.0000116224.51189.80","article-title":"Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension","volume":"43","author":"Von Wowern","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0125","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/HJH.0b013e3281ab6c7d","article-title":"Job strain, decision latitude and alpha2B-adrenergic receptor polymorphism significantly interact, and associate with high blood pressures in men","volume":"25","author":"Ohlin","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nm1553","article-title":"Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure","volume":"13","author":"Lymperopoulos","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0135","doi-asserted-by":"crossref","first-page":"16378","DOI":"10.1074\/jbc.M109.077859","article-title":"Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction","volume":"285","author":"Lymperopoulos","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0140","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.mt.6300371","article-title":"Modulation of adrenal catecholamine secretion by in vivo gene transfer and manipulation of G protein-coupled receptor kinase-2 activity","volume":"16","author":"Lymperopoulos","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molmed.2007.10.005","article-title":"Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation","volume":"13","author":"Lymperopoulos","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.RES.81.6.1021","article-title":"Beta-arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation","volume":"81","author":"Conner","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0155","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/HYPERTENSIONAHA.113.02043","article-title":"Negative impact of \u03b2-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms","volume":"63","author":"Bathgate-Siryk","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0160","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/HYPERTENSIONAHA.117.09817","article-title":"\u03b2-Arrestin2 improves post-myocardial infarction heart failure via Sarco(endo)plasmic reticulum Ca2+-ATPase-dependent positive Inotropy in cardiomyocytes","volume":"70","author":"McCrink","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0165","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.jacc.2017.10.008","article-title":"Cardiac \u03b2arrestin2 improves contractility and adverse remodeling in heart failure, but is underexpressed in humans","volume":"70","author":"McCrink","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0170","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2217\/pgs-2016-0094","article-title":"\u03b21-adrenoceptor Arg389Gly polymorphism confers differential \u03b2-arrestin-binding tropism in cardiac myocytes","volume":"17","author":"McCrink","year":"2016","journal-title":"Pharmacogenomics"},{"issue":"suppl #1","key":"10.1016\/bs.pmbts.2018.07.003_bb0175","article-title":"Carvedilol uniquely stimulates \u03b2arrestin2-dependent SERCA2a activity via the \u03b21-adrenergic receptor to exert positive inotropy in cardiac myocytes","volume":"32","author":"Parker","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068351","article-title":"\u03b2-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction","volume":"8","author":"Watari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0185","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI31901","article-title":"Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection","volume":"117","author":"Noma","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0190","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1073\/pnas.0607583103","article-title":"Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes","volume":"103","author":"Rajagopal","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0195","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI25330","article-title":"Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q\/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice","volume":"115","author":"Zhai","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0200","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.116.024482","article-title":"Long-term biased \u03b2-Arrestin signaling improves cardiac structure and function in dilated cardiomyopathy","volume":"135","author":"Ryba","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/CIRCRESAHA.108.172338","article-title":"Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration","volume":"103","author":"Kim","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0210","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1074\/jbc.M808176200","article-title":"Independent beta-arrestin2 and Gq\/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor","volume":"284","author":"Kim","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0215","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1074\/jbc.M115.684357","article-title":"\u03b2-Arrestin-mediated angiotensin II signaling controls the activation of ARF6 protein and endocytosis in migration of vascular smooth muscle cells","volume":"291","author":"Charles","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2014.12.018","article-title":"Clathrin-dependent internalization of the angiotensin II AT\u2081A receptor links receptor internalization to COX-2 protein expression in rat aortic vascular smooth muscle cells","volume":"748","author":"Morinelli","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0225","doi-asserted-by":"crossref","first-page":"C1176","DOI":"10.1152\/ajpcell.00235.2012","article-title":"Angiotensin II activates NF-\u03baB through AT1A receptor recruitment of \u03b2-arrestin in cultured rat vascular smooth muscle cells","volume":"304","author":"Morinelli","year":"2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0230","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2010.08.635","article-title":"Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels","volume":"57","author":"Lymperopoulos","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0240","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.09.070","article-title":"Different potencies of angiotensin receptor blockers at suppressing adrenal \u03b2-arrestin1-dependent post-myocardial infarction hyperaldosteronism","volume":"64","author":"Lymperopoulos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0245","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal \u03b2arrestin1-dependent aldosterone production by ARBs: head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0250","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00202.2011","article-title":"Arrestins 2 and 3 differentially regulate ETA and P2Y2 receptor-mediated cell signaling and migration in arterial smooth muscle","volume":"302","author":"Morris","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0255","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1440-1681.12696","article-title":"GRK2\/\u03b2-arrestin mediates arginine vasopressin-induced cardiac fibroblast proliferation","volume":"44","author":"Chen","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.98.1.93","article-title":"Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus","volume":"98","author":"Barak","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0265","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.109.061804","article-title":"Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments","volume":"77","author":"Rochdi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0270","doi-asserted-by":"crossref","first-page":"E1028","DOI":"10.1073\/pnas.1112422109","article-title":"Engagement of \u03b2-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1\/2 activation","volume":"109","author":"Oligny-Longpr\u00e9","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0275","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.cellsig.2008.05.009","article-title":"Vasopressin up-regulates the expression of growth-related immediate-early genes via two distinct EGF receptor transactivation pathways","volume":"20","author":"Fuentes","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rsob.170207","article-title":"Identification and functional characterization of arginine vasopressin receptor 1A: atypical chemokine receptor 3 heteromers in vascular smooth muscle","volume":"8","author":"Albee","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0285","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI36806","article-title":"Beta-arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice","volume":"119","author":"Walters","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0290","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1160\/TH11-06-0430","article-title":"\u03b2-arrestin-1 participates in thrombosis and regulates integrin aIIb\u03b23 signalling without affecting P2Y receptors desensitisation and function","volume":"107","author":"Schaff","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0295","doi-asserted-by":"crossref","first-page":"13867","DOI":"10.1074\/jbc.M117.782359","article-title":"Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of \u03b2-arrestin","volume":"292","author":"Smith","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/cvr\/cvq249","article-title":"G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling","volume":"89","author":"Morris","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0305","doi-asserted-by":"crossref","first-page":"C179","DOI":"10.1152\/ajpcell.00079.2015","article-title":"Defining the roles of arrestin2 and arrestin3 in vasoconstrictor receptor desensitization in hypertension","volume":"309","author":"Willets","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0310","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1074\/jbc.M110.118018","article-title":"Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets","volume":"286","author":"Li","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.114.091595","article-title":"The physical association of the P2Y12 receptor with PAR4 regulates arrestin-mediated Akt activation","volume":"86","author":"Khan","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0320","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2016-06-720581","article-title":"Occupancy of human EPCR by protein C induces \u03b2-arrestin-2 biased PAR1 signaling by both APC and thrombin","volume":"128","author":"Roy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0325","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tips.2015.06.002","article-title":"Apelin, Elabela\/Toddler, biased agonists as novel therapeutic agents in the cardiovascular system","volume":"36","author":"Yang","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0330","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0340","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature10407","article-title":"SUMO1-dependent modulation of SERCA2a in heart failure","volume":"477","author":"Kho","year":"2011","journal-title":"Nature"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0345","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1073\/pnas.0804745105","article-title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0350","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0355","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00210-011-0705-z","article-title":"G\u03b1i2 signaling: friend or foe in cardiac injury and heart failure?","volume":"385","author":"Kaur","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0360","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M112.357871","article-title":"Induction of cardiac fibrosis by \u03b2-blocker in G protein-independent and G protein-coupled receptor kinase 5\/\u03b2-arrestin2-dependent signaling pathways","volume":"287","author":"Nakaya","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0365","doi-asserted-by":"crossref","first-page":"E4107","DOI":"10.1073\/pnas.1606267113","article-title":"\u03b2-Arrestin-biased signaling through the \u03b22-adrenergic receptor promotes cardiomyocyte contraction","volume":"113","author":"Carr","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0370","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/jpet.115.227959","article-title":"Recruitment of \u03b2-arrestin 1 and 2 to the \u03b22-adrenoceptor: analysis of 65 ligands","volume":"355","author":"Littmann","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0375","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature13430","article-title":"Visualization of arrestin recruitment by a G-protein-coupled receptor","volume":"512","author":"Shukla","year":"2014","journal-title":"Nature"},{"issue":"484","key":"10.1016\/bs.pmbts.2018.07.003_bb0380","article-title":"Genetic evidence that \u03b2-arrestins are dispensable for the initiation of \u03b22-adrenergic receptor signaling to ERK","volume":"10","author":"O'Hayre","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0385","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41467-017-01855-z","article-title":"G\u03b1i is required for carvedilol-induced \u03b21 adrenergic receptor \u03b2-arrestin biased signaling","volume":"8","author":"Wang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0390","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1172\/JCI119381","article-title":"G-protein-coupled receptor kinase activity is increased in hypertension","volume":"99","author":"Gros","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0395","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.110.231233","article-title":"G protein coupled receptor kinases as therapeutic targets in cardiovascular disease","volume":"109","author":"Belmonte","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0400","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biocel.2016.02.003","article-title":"GPCRs of adrenal chromaffin cells & catecholamines: the plot thickens","volume":"77","author":"Lymperopoulos","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0405","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/me.2015-1305","article-title":"GRK2 up-regulation creates a positive feedback loop for catecholamine production in chromaffin cells","volume":"30","author":"Jafferjee","year":"2016","journal-title":"Mol Endocrinol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0410","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jacc.2017.01.016","article-title":"GRK2 regulates \u03b12-adrenergic receptor-dependent catecholamine release in human adrenal chromaffin cells","volume":"69","author":"Cannavo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0415","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.phrs.2017.05.009","article-title":"Biased agonism\/antagonism at the AngII-AT1 receptor: implications for adrenal aldosterone production and cardiovascular therapy","volume":"125","author":"Maning","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/138161212799040475","article-title":"Beta-arrestin biased agonism\/antagonism at cardiovascular seven transmembrane-spanning receptors","volume":"18","author":"Lymperopoulos","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0425","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4899-1376-0_7","article-title":"Cardiac effects of AII. AT1A receptor signaling, desensitization, and internalization","volume":"396","author":"Thomas","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0430","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nchembio.961","article-title":"Deciphering biased-agonism complexity reveals a new active AT1 receptor entity","volume":"8","author":"Sauli\u00e8re","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0435","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0904361106","article-title":"Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands","volume":"106","author":"Zidar","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0440","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1742-7843.2007.00064.x","article-title":"Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes","volume":"100","author":"Aplin","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0445","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1124\/jpet.110.173005","article-title":"Selectively engaging \u03b2-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance","volume":"335","author":"Violin","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0450","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCHEARTFAILURE.111.962571","article-title":"Cardiorenal actions of TRV120027, a novel \u00df-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure","volume":"4","author":"Boerrigter","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0455","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCHEARTFAILURE.112.969220","article-title":"TRV120027, a novel beta-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure","volume":"5","author":"Boerrigter","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0460","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2000769","article-title":"Beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress","volume":"3","author":"Rakesh","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0465","doi-asserted-by":"crossref","first-page":"14426","DOI":"10.1073\/pnas.1609308113","article-title":"\u03b2-Arrestin mediates the Frank-Starling mechanism of cardiac contractility","volume":"113","author":"Abraham","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0470","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pharmthera.2010.11.001","article-title":"Endothelium-derived vasoactive agents, AT1 receptors and inflammation","volume":"131","author":"MacKenzie","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0475","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1074\/jbc.M808463200","article-title":"Beta-arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation","volume":"284","author":"Ahn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0480","doi-asserted-by":"crossref","first-page":"26155","DOI":"10.1074\/jbc.M114.595728","article-title":"Arrestin-dependent angiotensin AT1 receptor signaling regulates Akt and mTor-mediated protein synthesis","volume":"289","author":"Kendall","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0485","doi-asserted-by":"crossref","first-page":"18872","DOI":"10.1074\/jbc.M113.472381","article-title":"The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers","volume":"288","author":"Wilson","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0490","first-page":"3","article-title":"Inhibition of 5-Hydroxytryptamine receptor 2B reduced vascular restenosis and mitigated the \u03b2-arrestin2-mammalian target of rapamycin\/p70S6K pathway","volume":"7","author":"Liu","year":"2018","journal-title":"Am Heart Assoc"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0495","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.aac9187","article-title":"Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension","volume":"9","author":"Nishimura","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0500","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1074\/jbc.M115.687129","article-title":"Ubiquitin-specific protease 20 regulates the reciprocal functions of \u03b2-arrestin2 in toll-like receptor 4-promoted nuclear factor \u03baB (NF\u03baB) activation","volume":"291","author":"Jean-Charles","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0505","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4330\/wjc.v9.i3.200","article-title":"Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: implications for heart failure therapy","volume":"9","author":"Lymperopoulos","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0510","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1074\/jbc.M117.813139","article-title":"Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by \u03b2-arrestins","volume":"293","author":"T\u00f3th","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0515","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/JME-14-0125","article-title":"Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor","volume":"53","author":"Balakumar","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0520","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1747-0285.2006.00444.x","article-title":"Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation","volume":"68","author":"Nikiforovich","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.226","article-title":"Structure-activity relationship study of angiotensin II analogs in terms of \u03b2-arrestin-dependent signaling to aldosterone production","volume":"4","author":"Valero","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0530","doi-asserted-by":"crossref","first-page":"14335","DOI":"10.1038\/ncomms14335","article-title":"Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0535","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2008.03.006","article-title":"Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis","volume":"199","author":"Ivey","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11906-018-0811-0","article-title":"Vasopressin, central autonomic control and blood pressure regulation","volume":"20","author":"Lozi\u0107","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0545","doi-asserted-by":"crossref","first-page":"17201","DOI":"10.1074\/jbc.M910348199","article-title":"Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors","volume":"275","author":"Oakley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0550","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/ATVBAHA.111.236315","article-title":"Niacin in cardiovascular disease: recent preclinical and clinical developments","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0555","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0560","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s12272-015-0560-4","article-title":"Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor","volume":"38","author":"Kim","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0565","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0570","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1182\/blood-2004-07-2893","article-title":"P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms","volume":"105","author":"Hardy","year":"2005","journal-title":"Blood"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0575","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1476-5381.2010.00705.x","article-title":"Signal transduction by protease-activated receptors","volume":"160","author":"Soh","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0580","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0585","doi-asserted-by":"crossref","first-page":"E1372","DOI":"10.1073\/pnas.1112482108","article-title":"Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through \u03b2-arrestin and dishevelled-2 scaffolds","volume":"108","author":"Soh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0590","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0595","doi-asserted-by":"crossref","first-page":"32627","DOI":"10.1074\/jbc.M110.127167","article-title":"By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization","volume":"285","author":"Iturrioz","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0600","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1096\/fj.09-140715","article-title":"Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist","volume":"24","author":"Iturrioz","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0605","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0610","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1039\/C6OB02247B","article-title":"Structure-activity relationship of novel macrocyclic biased apelin receptor agonists","volume":"15","author":"Murza","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/molecules22030344","article-title":"Sphingosine 1-phosphate receptor 1 signaling in mammalian cells","volume":"22","author":"Pyne","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0620","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0625","first-page":"102","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0630","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/CIRCRESAHA.107.170779","article-title":"Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages","volume":"102","author":"Hughes","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0635","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2015.09.001","article-title":"Emerging functional divergence of \u03b2-arrestin isoforms in GPCR function","volume":"26","author":"Srivastava","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0640","doi-asserted-by":"crossref","first-page":"24726","DOI":"10.3390\/ijms141224726","article-title":"\u03b2Arrestins in cardiac G protein-coupled receptor signaling and function: partners in crime or \u201cgood cop, bad cop\u201d?","volume":"14","author":"Lymperopoulos","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0645","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jmb.2010.12.034","article-title":"Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes","volume":"406","author":"Zhan","year":"2011","journal-title":"J Mol Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0650","doi-asserted-by":"crossref","first-page":"20991","DOI":"10.1074\/jbc.M114.560680","article-title":"Identification of receptor binding-induced conformational changes in non-visual arrestins","volume":"289","author":"Zhuo","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2013.10.007","article-title":"Extensive shape shifting underlies functional versatility of arrestins","volume":"27","author":"Gurevich","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/bs.pmbts.2018.07.003_bb0660","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0704849104","article-title":"Functional specialization of beta-arrestin interactions revealed by proteomic analysis","volume":"104","author":"Xiao","year":"2007","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Progress in Molecular Biology and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318300966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117318300966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:25:58Z","timestamp":1751790358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117318300966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128162354"],"references-count":131,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2018.07.003","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}